Telehealth startup Midi broadens its scope

Fast-growing women’s telehealth health company Midi Health is expanding beyond menopause care into a broader range of services. The California-based company, which in February exceeded a valuation of more than $1 billion after a $100 million funding round, now offers care for conditions including PMOS and metabolic health, with more offerings planned. Midi, founded in 2021, uses AI-integrated tools to deliver care. It notes that women can now see their full range of care options, from clinical labs to hormone therapy to supplements, on one site. “The wider breadth of treatment options are designed to provide women with the care they deserve in every life stage,” Midi CEO and co-founder Joanna Strober says.